Literature DB >> 25265462

Fecal microbiota transplant after hematopoietic SCT: report of a successful case.

C G de Castro1, A J Ganc2, R L Ganc3, M S Petrolli4, N Hamerschlack1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25265462     DOI： 10.1038/bmt.2014.212

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Oral combined therapy with probiotics and alloantigen induces B cell-dependent long-lasting specific tolerance.

Authors:  Ana C T Mercadante; Suelen M Perobelli; Ana P G Alves; Triciana Gonçalves-Silva; Wallace Mello; Ana C Gomes-Santos; Anderson Miyoshi; Vasco Azevedo; Ana M C Faria; Adriana Bonomo
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

2.  The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.

Authors:  Ying Taur; Robert R Jenq; Miguel-Angel Perales; Eric R Littmann; Sejal Morjaria; Lilan Ling; Daniel No; Asia Gobourne; Agnes Viale; Parastoo B Dahi; Doris M Ponce; Juliet N Barker; Sergio Giralt; Marcel van den Brink; Eric G Pamer
Journal:  Blood       Date:  2014-06-17       Impact factor: 22.113

3.  Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient.

Authors:  K Neemann; D D Eichele; P W Smith; R Bociek; M Akhtari; A Freifeld
Journal:  Transpl Infect Dis       Date:  2012-11-02       Impact factor: 2.228

4.  Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.

Authors:  Colleen R Kelly; Chioma Ihunnah; Monika Fischer; Alexander Khoruts; Christina Surawicz; Anita Afzali; Olga Aroniadis; Amy Barto; Thomas Borody; Andrea Giovanelli; Shelley Gordon; Michael Gluck; Elizabeth L Hohmann; Dina Kao; John Y Kao; Daniel P McQuillen; Mark Mellow; Kevin M Rank; Krishna Rao; Arnab Ray; Margot A Schwartz; Namita Singh; Neil Stollman; David L Suskind; Stephen M Vindigni; Ilan Youngster; Lawrence Brandt
Journal:  Am J Gastroenterol       Date:  2014-06-03       Impact factor: 10.864
  4 in total
  23 in total

Review 1.  Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation.

Authors:  Tessa M Andermann; Andrew Rezvani; Ami S Bhatt
Journal:  Curr Hematol Malig Rep       Date:  2016-02       Impact factor: 3.952

2.  Fecal microbiota transplant for recurrent Clostridium difficile infection after peripheral autologous stem cell transplant for diffuse large B-cell lymphoma.

Authors:  C Mittal; N Miller; A Meighani; B R Hart; A John; M Ramesh
Journal:  Bone Marrow Transplant       Date:  2015-04-20       Impact factor: 5.483

3.  Gut microbiota alterations associated with antibody-mediated rejection after kidney transplantation.

Authors:  Junpeng Wang; Xin Li; Xiaoqiang Wu; Zhiwei Wang; Chan Zhang; Guanghui Cao; Shun Liu; Tianzhong Yan
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-24       Impact factor: 4.813

Review 4.  The Microbiota in Hematologic Malignancies.

Authors:  Yajing Song; Bryan Himmel; Lars Öhrmalm; Peter Gyarmati
Journal:  Curr Treat Options Oncol       Date:  2020-01-11

Review 5.  Gut microbiota and hematopoietic stem cell transplantation: where do we stand?

Authors:  D Zama; E Biagi; R Masetti; P Gasperini; A Prete; M Candela; P Brigidi; A Pession
Journal:  Bone Marrow Transplant       Date:  2016-06-27       Impact factor: 5.483

6.  Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut.

Authors:  Kazuhiko Kakihana; Yuki Fujioka; Wataru Suda; Yuho Najima; Go Kuwata; Satoshi Sasajima; Iyo Mimura; Hidetoshi Morita; Daisuke Sugiyama; Hiroyoshi Nishikawa; Masahira Hattori; Yutaro Hino; Shuntaro Ikegawa; Keita Yamamoto; Takashi Toya; Noriko Doki; Koichi Koizumi; Kenya Honda; Kazuteru Ohashi
Journal:  Blood       Date:  2016-07-26       Impact factor: 22.113

7.  Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.

Authors:  Zachariah DeFilipp; Jonathan U Peled; Shuli Li; Jasmin Mahabamunuge; Zeina Dagher; Ann E Slingerland; Candice Del Rio; Betsy Valles; Maria E Kempner; Melissa Smith; Jami Brown; Bimalangshu R Dey; Areej El-Jawahri; Steven L McAfee; Thomas R Spitzer; Karen K Ballen; Anthony D Sung; Tara E Dalton; Julia A Messina; Katja Dettmer; Gerhard Liebisch; Peter Oefner; Ying Taur; Eric G Pamer; Ernst Holler; Michael K Mansour; Marcel R M van den Brink; Elizabeth Hohmann; Robert R Jenq; Yi-Bin Chen
Journal:  Blood Adv       Date:  2018-04-10

Review 8.  Clostridioides difficile Infection in the Stem Cell Transplant and Hematologic Malignancy Population.

Authors:  Elizabeth Ann Misch; Nasia Safdar
Journal:  Infect Dis Clin North Am       Date:  2019-06       Impact factor: 5.982

Review 9.  The gut microbiota in transplant patients.

Authors:  Pearlie P Chong; Andrew Y Koh
Journal:  Blood Rev       Date:  2019-08-29       Impact factor: 8.250

Review 10.  The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.

Authors:  Tessa M Andermann; Jonathan U Peled; Christine Ho; Pavan Reddy; Marcie Riches; Rainer Storb; Takanori Teshima; Marcel R M van den Brink; Amin Alousi; Sophia Balderman; Patrizia Chiusolo; William B Clark; Ernst Holler; Alan Howard; Leslie S Kean; Andrew Y Koh; Philip L McCarthy; John M McCarty; Mohamad Mohty; Ryotaro Nakamura; Katy Rezvani; Brahm H Segal; Bronwen E Shaw; Elizabeth J Shpall; Anthony D Sung; Daniela Weber; Jennifer Whangbo; John R Wingard; William A Wood; Miguel-Angel Perales; Robert R Jenq; Ami S Bhatt
Journal:  Biol Blood Marrow Transplant       Date:  2018-02-19       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.